CCL21 and Parkinson disease: Studies also observed that the loss of function of one of the PD candidate genes PARK7 (DJ-1) decreases the expression of SLC25A27 (Xu et al., 2018), highlighting the significance of SLC25A27 and the SLC family of genes as a potential therapeutic targets for the treatment of PD.